FLAREX Drug Patent Profile
Which patents cover Flarex, and what generic alternatives are available?
Flarex is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in FLAREX is fluorometholone acetate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the fluorometholone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLAREX?
- What are the global sales for FLAREX?
- What is Average Wholesale Price for FLAREX?
Summary for FLAREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Patent Applications: | 2,320 |
| Drug Prices: | Drug price information for FLAREX |
| What excipients (inactive ingredients) are in FLAREX? | FLAREX excipients list |
| DailyMed Link: | FLAREX at DailyMed |
Pharmacology for FLAREX
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for FLAREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | FLAREX | fluorometholone acetate | SUSPENSION/DROPS;OPHTHALMIC | 019079-001 | Feb 11, 1986 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
